This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Slug is a transcriptional repressor that is expressed in pluripotent hematopoietic stem cells (HSCs). By studying mice deficient for both Slug and p53 or Slug and Puma, we have established that Slug acts downstream of p53 and upstream of Puma to control the fate of myeloid progenitor cells exposed to genotoxic stress in vivo. These findings implicate a vital anti-apoptotic role for Slug in the response of hematopoietic progenitors to genotoxic stress. However, these findings do not yet provide direct insight into the role of Slug in the protection of pluripotent hematopoietic stem cells (HSCs) from death due to DNA damage. Although we know endogenous Slug is normally expressed in both long- and short-term repopulating hematopoietic stem cells (HSCs), its roles in regulation of HSCs remain to be established. Thus, we will address these critical questions: (i) Is Slug indispensable for maintaining the integrity of HSC under steady-state conditions and, if so, by which mechanism(s)? (ii) Does Slug play an essential role in regulating HSCs self-renewal under genotoxic stress conditions?

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
2P20RR018789-06
Application #
7720708
Study Section
Special Emphasis Panel (ZRR1-RI-6 (01))
Project Start
2008-09-04
Project End
2009-05-31
Budget Start
2008-09-04
Budget End
2009-05-31
Support Year
6
Fiscal Year
2008
Total Cost
$222,715
Indirect Cost
Name
Maine Medical Center
Department
Type
DUNS #
071732663
City
Portland
State
ME
Country
United States
Zip Code
04102
Duarte, Christine W; Black, Adam W; Lucas, F Lee et al. (2017) Cancer incidence in patients with hereditary hemorrhagic telangiectasia. J Cancer Res Clin Oncol 143:209-214
Caron, Jennifer M; Ames, Jacquelyn J; Contois, Liangru et al. (2016) Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope. Am J Pathol 186:1649-61
Stohn, J Patrizia; Wang, Qiaozeng; Siviski, Matthew E et al. (2015) Cthrc1 controls adipose tissue formation, body composition, and physical activity. Obesity (Silver Spring) 23:1633-42
Ufkin, Melanie L; Peterson, Sarah; Yang, Xuehui et al. (2014) miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia. Leuk Res 38:402-10
He, Qing; Yang, Xuehui; Gong, Yan et al. (2014) Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity. J Bone Miner Res 29:1217-31
Motyl, Katherine J; Bishop, Kathleen A; DeMambro, Victoria E et al. (2013) Altered thermogenesis and impaired bone remodeling in Misty mice. J Bone Miner Res 28:1885-97
Bai, Hao; Chen, Kang; Gao, Yong-Xing et al. (2012) Bcl-xL enhances single-cell survival and expansion of human embryonic stem cells without affecting self-renewal. Stem Cell Res 8:26-37
Stohn, J Patrizia; Perreault, Nicole G; Wang, Qiaozeng et al. (2012) Cthrc1, a novel circulating hormone regulating metabolism. PLoS One 7:e47142
Kirov, Aleksandr; Al-Hashimi, Huda; Solomon, Phil et al. (2012) Phosphatidylserine externalization and membrane blebbing are involved in the nonclassical export of FGF1. J Cell Biochem 113:956-66
Singh, Seema; Verma, Rakesh; Pradeep, Anamika et al. (2012) Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles. PLoS One 7:e29064

Showing the most recent 10 out of 102 publications